Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvac

Condition:   Healthy Interventions:   Biological: GamTBvac vaccine;   Biological: placebo Sponsors:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation;   contract research organization Cromos Pharma Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials